Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer-Reference-Cited by-同舟云学术

Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer

Published:2013-03-08 Issue:3 Volume:8 Page:e58089
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bradshaw-Pierce Erica L.,Pitts Todd M.,Kulikowski Gillian,Selby Heather,Merz Andrea L.,Gustafson Daniel L.,Serkova Natalie J.,Eckhardt S. Gail,Weekes Colin D.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group;MJ Moore;J Clin Oncol,2007

2. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival;JA Bonner;Lancet Oncol,2010

3. Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck;M Suntharalingam;Int J Radiat Oncol Biol Phys,2012

4. Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial;J Ocvirk;World J Gastroenterol,2010

5. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200;BJ Giantonio;J Clin Oncol,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Gut Microbiota in Predisposition to Colon Cancer: A Narrative Review;Indian Journal of Microbiology;2024-03-29

2. HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expression;International Journal of Molecular Medicine;2023-07-19

3. ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer;BMC Cancer;2022-10-29

4. Mimicking and surpassing the xenograft model with cancer-on-chip technology;EBioMedicine;2021-04

5. The role of mouse models in colorectal cancer research—The need and the importance of the orthotopic models;Animal Models and Experimental Medicine;2020-03